NCT00731770 Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep Status COMPLETED Phase PHASE4
NCT00731393 Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04 Status COMPLETED Phase PHASE3
NCT00731250 A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model Status COMPLETED Phase PHASE1
NCT00731211 Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00731029 Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03 Status COMPLETED Phase PHASE3
NCT00730847 A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards. Status TERMINATED Phase PHASE4
NCT00730795 Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults Status COMPLETED Phase PHASE1
NCT00730782 Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers Status COMPLETED Phase PHASE1
NCT00730756 A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis Status COMPLETED Phase PHASE2
NCT00730405 Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis Status COMPLETED Phase PHASE2
NCT00729430 Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging Status COMPLETED Phase PHASE3
NCT00729001 Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. Status COMPLETED Phase PHASE2
NCT00728897 A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. Status COMPLETED Phase PHASE1
NCT00728052 A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers Status COMPLETED Phase PHASE1
NCT00727597 A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT Status COMPLETED Phase PHASE3
NCT00726323 A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) Status COMPLETED Phase PHASE2
NCT00725764 Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck Status COMPLETED Phase PHASE2